Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials.
Yutaka KondoKohei OtaHaruki ImuraNaoki HaraNobuaki ShimePublished in: Journal of intensive care (2020)
The prolonged infusion of β-lactam antibiotics significantly improved upon attaining the target plasma concentration and clinical cure without increasing the adverse event or the occurrence of antibiotic-resistant bacteria. Prolonged infusion could not improve hospital mortality although an improvement was shown for studies published in or after 2015. Further studies are warranted as suggested by our TSA results.
Keyphrases
- septic shock
- low dose
- end stage renal disease
- ejection fraction
- chronic kidney disease
- clinical trial
- peritoneal dialysis
- case control
- intensive care unit
- prognostic factors
- acute kidney injury
- high dose
- study protocol
- gram negative
- cardiovascular disease
- patient reported outcomes
- phase ii
- electronic health record
- acute care
- placebo controlled